Biopharma's Path To MES In The Cloud

This interview highlights the transformative journey of biopharmaceutical companies as they embrace cloud-based Manufacturing Execution Systems (MES). This transition is pivotal, offering enhanced scalability, flexibility, and real-time data access—critical elements for meeting stringent regulatory demands and optimizing operational efficiency. By leveraging cloud technology, organizations can streamline their manufacturing processes, foster collaboration, and ensure compliance while significantly reducing IT overhead. The necessity of selecting an appropriate cloud solution and partner to navigate this complex transformation successfully is crucial. Körber provides a robust suite of offerings tailored for the pharmaceutical and biotech sectors, including the versatile PAS-X MES, which supports digital innovation and sustainability. Moreover, insights from industry experts Ciera Clayton of BioPhorum and Kortney Gunther of Körber reveal the collaborative efforts necessary to address the challenges posed by cloud adoption. As biopharmaceutical companies continue to navigate the complexities of digital transformation, Körber remains committed to supporting their journey, ensuring they are equipped to thrive in an evolving landscape.
Access the full interview to learn more.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.